NCT04149691: Safety, Tolerability and Pharmacokinetics of Oral CPL304110, in Adult Subjects With Advanced Solid Malignancies |
|
|
| Recruiting | 1 | 42 | Europe | CPL304110, PG19 | Celon Pharma SA, National Center for Research and Development, Poland | Gastric Cancer, Bladder Cancer, Squamous Non-small Cell Lung Cancer, Cholangiocarcinoma, Sarcoma, Endometrial Cancer, Other Solid Tumours | 06/24 | 06/24 | | |
